ono-5334
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2007 (NCT00532337)
Timeline
Indications
Mechanism of action
- Cathepsin KINHIBITOR
CTSK inhibitor
Chemistry & pharmacology
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4802176 ↗
Also known as
- ono-5334
- ono-5334
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01384188 | Phase 1/Phase 2 (Phase 2) | Jun 1, 2011 | Ono Pharmaceuticals |
| NCT00532337 | Phase 2 | Oct 1, 2007 | Ono Pharmaceuticals |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ono Pharmaceuticals | For profit | 2 | 2 | 1 | 2007 |
1 organizations
Page 1 / 1